Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients.
about
Comparative study of the anti-human cytomegalovirus activities and toxicities of a tetrahydrofuran phosphonate analogue of guanosine and cidofovirAntiviral properties of a series of 1,6-naphthyridine and 7, 8-dihydroisoquinoline derivatives exhibiting potent activity against human cytomegalovirusA novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products.Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients.Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection.Inactivation of enveloped virus by laser-driven protein aggregation.Rhesus cytomegalovirus is similar to human cytomegalovirus in susceptibility to benzimidazole nucleosidesThe Cys607-->Tyr change in the UL97 phosphotransferase confers ganciclovir resistance to two human cytomegalovirus strains recovered from two immunocompromised patients.Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragmentsSingle amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovSynthesis and antiviral activities of 3-aralkylthiomethylimidazo[1,2-b]pyridazine derivatives.
P2860
Q28343171-2FE9A169-3EE4-4CFF-A2CF-4BB6E5E5A941Q28344048-319E9B78-685D-4580-9B52-D91DDBEF8AAEQ28348812-B8577B75-16D6-418F-95C2-5AF7265C7B46Q33558361-6456F788-4F2A-4FE0-B9EC-E7DB3D49DE68Q33592427-2BA8E5BF-70AE-4D9D-9FB4-83F1FEF4755DQ33662067-2D3EDB76-712F-4B59-A569-0C7AE1517AD5Q34504426-5075BED0-A482-489F-AA60-D39783649F0DQ35124909-8A0D5E34-C420-4009-B322-433B6E209BB2Q39556801-61F5C80E-5115-4954-ACB2-FB74ED9CE5E9Q39582502-B93ADD99-B4DF-4B59-AFFE-CD6FDB99A76EQ39873608-51E8965D-5E1B-4BB0-91D1-FD95E01BDDA6Q40622209-954927C8-72E4-463F-949A-7A69AC456A06
P2860
Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Double resistance to ganciclov ...... recovered from AIDS patients.
@en
type
label
Double resistance to ganciclov ...... recovered from AIDS patients.
@en
prefLabel
Double resistance to ganciclov ...... recovered from AIDS patients.
@en
P2093
P2860
P356
P1476
Double resistance to ganciclov ...... recovered from AIDS patients.
@en
P2093
P2860
P304
P356
10.1002/JMV.1890470309
P577
1995-11-01T00:00:00Z